Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study.

Autor: Emery, P., Bingham III, C. O., Burmester, G. R., Bykerk, V. P., Furst, D. E., Mariette, X., van der Heijde, D., van Vollenhoven, R., Arendt, C., Mountian, I., Purcaru, O., Tatla, D., VanLunen, B., Weinblatt, M. E., Bingham, C O 3rd

Publikováno v: Annals of the Rheumatic Diseases; Jan2017, Vol. 76 Issue 1, p96-104, 9p, 1 Diagram, 3 Charts, 4 Graphs

Definitions and validation criteria for biomarkers and surrogate endpoints: Development and testing of a quantitative hierarchical levels of evidence schema

Autor: Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., Brooks, P., Simon, L., Strand, V., Conaghan, P. G., Østergaard, M., Walter Maksymowych, Landewé, R., Bresnihan, B., Tak, P. -P, Wakefield, R., Mease, P., Bingham Iii, C. O., Hughes, M., Altman, D., Buyse, M., Galbraith, S., Wells, G.

Publikováno v: Scopus-Elsevier
Journal of rheumatology, 34(3), 607-615. Journal of Rheumatology

OBJECTIVE: There are clear advantages to using biomarkers and surrogate endpoints, but concerns about clinical and statistical validity and systematic methods to evaluate these aspects hinder their efficient application. Our objective was to review t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eb368acedc05d8526ce5666170acc08f
http://www.scopus.com/inward/record.url?eid=2-s2.0-33847628809&partnerID=MN8TOARS

The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study.

Autor: Shadick NA; Department of Medicine, Division of Rheumatology/Immunology and Allergy, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA., Liang MH, Partridge AJ, Bingham III CO, Wright E, Fossel AH, Sheffer AL

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 1999 Jul; Vol. 104 (1), pp. 123-7.